Cargando…

Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT

OBJECTIVE: To assess the diagnostic value of spectral parameters in differentiating adrenal adenomas from metastases based on dual-layer detector spectral CT (DLSCT). MATERIALS AND METHODS: Patients with adenomas or metastases who underwent enhanced DLSCT of the adrenals were enrolled. The CT values...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lei-di, Yue, Xiao-fei, Wu, Lin-xia, Yang, Ming, Chen, Yan, Yu, Jie, Diao, Nan, Zhang, Xiao-hui, Zhu, Liang-ru, Han, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423139/
https://www.ncbi.nlm.nih.gov/pubmed/37278828
http://dx.doi.org/10.1007/s00432-023-04931-8
_version_ 1785089380438769664
author Wu, Lei-di
Yue, Xiao-fei
Wu, Lin-xia
Yang, Ming
Chen, Yan
Yu, Jie
Diao, Nan
Zhang, Xiao-hui
Zhu, Liang-ru
Han, Ping
author_facet Wu, Lei-di
Yue, Xiao-fei
Wu, Lin-xia
Yang, Ming
Chen, Yan
Yu, Jie
Diao, Nan
Zhang, Xiao-hui
Zhu, Liang-ru
Han, Ping
author_sort Wu, Lei-di
collection PubMed
description OBJECTIVE: To assess the diagnostic value of spectral parameters in differentiating adrenal adenomas from metastases based on dual-layer detector spectral CT (DLSCT). MATERIALS AND METHODS: Patients with adenomas or metastases who underwent enhanced DLSCT of the adrenals were enrolled. The CT values of virtual non-contrast images (CT(VNC)), iodine density (ID) values, and Z-effective (Z-eff) values, the normalized iodine density (NID) values, slopes of spectral HU curves (s-SHC), and iodine-to-CT(VNC) ratios of the tumors were measured in each phase. Receiver operating characteristic (ROC) curves were used to compare the diagnostic values. RESULTS: Ninety-nine patients with 106 adrenal lesions (63 adenomas, 43 metastases) were included. In the venous phase, all spectral parameters were significantly different between adenomas and metastases (all p < 0.05). The combined spectral parameters showed a better diagnostic performance in the venous phase than in other phase (p < 0.05). The iodine-to-CT(VNC) value had a larger area under the ROC curve (AUC) than the other spectral parameters in the differential diagnosis of adenomas and metastases, with a diagnostic sensitivity and specificity of 74.4% and 91.9%, respectively. In the differential diagnosis of lipid-rich adenomas, lipid-poor adenomas and metastases, the CT(VNC) value and s-SHC value also had a larger AUC than the other spectral parameters, with a diagnostic sensitivity of 97.7%, 79.1% and specificity of 91.2%, 93.1%, respectively. CONCLUSION: On DLSCT, the combined spectral parameters in the venous phase could help better distinguish adrenal adenomas from metastases. The iodine-to-CT(VNC), CT(VNC) and s-SHC values had the highest AUC values in differentiating adenomas, lipid-rich adenomas and lipid-poor adenomas from metastases, respectively. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04931-8.
format Online
Article
Text
id pubmed-10423139
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104231392023-08-14 Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT Wu, Lei-di Yue, Xiao-fei Wu, Lin-xia Yang, Ming Chen, Yan Yu, Jie Diao, Nan Zhang, Xiao-hui Zhu, Liang-ru Han, Ping J Cancer Res Clin Oncol Research OBJECTIVE: To assess the diagnostic value of spectral parameters in differentiating adrenal adenomas from metastases based on dual-layer detector spectral CT (DLSCT). MATERIALS AND METHODS: Patients with adenomas or metastases who underwent enhanced DLSCT of the adrenals were enrolled. The CT values of virtual non-contrast images (CT(VNC)), iodine density (ID) values, and Z-effective (Z-eff) values, the normalized iodine density (NID) values, slopes of spectral HU curves (s-SHC), and iodine-to-CT(VNC) ratios of the tumors were measured in each phase. Receiver operating characteristic (ROC) curves were used to compare the diagnostic values. RESULTS: Ninety-nine patients with 106 adrenal lesions (63 adenomas, 43 metastases) were included. In the venous phase, all spectral parameters were significantly different between adenomas and metastases (all p < 0.05). The combined spectral parameters showed a better diagnostic performance in the venous phase than in other phase (p < 0.05). The iodine-to-CT(VNC) value had a larger area under the ROC curve (AUC) than the other spectral parameters in the differential diagnosis of adenomas and metastases, with a diagnostic sensitivity and specificity of 74.4% and 91.9%, respectively. In the differential diagnosis of lipid-rich adenomas, lipid-poor adenomas and metastases, the CT(VNC) value and s-SHC value also had a larger AUC than the other spectral parameters, with a diagnostic sensitivity of 97.7%, 79.1% and specificity of 91.2%, 93.1%, respectively. CONCLUSION: On DLSCT, the combined spectral parameters in the venous phase could help better distinguish adrenal adenomas from metastases. The iodine-to-CT(VNC), CT(VNC) and s-SHC values had the highest AUC values in differentiating adenomas, lipid-rich adenomas and lipid-poor adenomas from metastases, respectively. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04931-8. Springer Berlin Heidelberg 2023-06-06 2023 /pmc/articles/PMC10423139/ /pubmed/37278828 http://dx.doi.org/10.1007/s00432-023-04931-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Wu, Lei-di
Yue, Xiao-fei
Wu, Lin-xia
Yang, Ming
Chen, Yan
Yu, Jie
Diao, Nan
Zhang, Xiao-hui
Zhu, Liang-ru
Han, Ping
Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
title Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
title_full Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
title_fullStr Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
title_full_unstemmed Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
title_short Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
title_sort differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral ct
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423139/
https://www.ncbi.nlm.nih.gov/pubmed/37278828
http://dx.doi.org/10.1007/s00432-023-04931-8
work_keys_str_mv AT wuleidi differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT yuexiaofei differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT wulinxia differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT yangming differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT chenyan differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT yujie differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT diaonan differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT zhangxiaohui differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT zhuliangru differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct
AT hanping differentialdiagnosisofadrenaladenomasandmetastasesusingspectralparametersinduallayerdetectorspectralct